NAD+ pill tested in healthy volunteers: no major breakthrough yet
NCT ID NCT07336836
First seen Jan 17, 2026 · Last updated Jun 18, 2026 · Updated 22 times
Summary
This study tested a 5-day course of an oral NAD+ supplement in 60 healthy adults aged 45-75. Researchers measured changes in blood markers and NAD+ levels compared to a placebo. The goal was to understand the supplement's effects on health-related molecules and confirm safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ISB Bioanalytica, Inc.
Seattle, Washington, 98109, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.